[HTML][HTML] Promoter mutations and cellular distribution of telomerase in non-clear cell and clear cell hepatocellular carcinoma

W Huang, W Zhou, C Li, Y Yang, YK Shang, C Chen… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Reactivation of telomerase is a critical step in the development of hepatocellular carcinoma
(HCC). Here we identified the frequency of mutations in telomerase reverse transcriptase …

[HTML][HTML] Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma

JW Jang, JS Kim, HS Kim, KY Tak, SK Lee, HC Nam… - Cancers, 2021 - mdpi.com
Simple Summary Telomerase reverse transcriptase (TERT) mutations are the most frequent
genetic alterations in hepatocellular carcinoma (HCC). However, integrative analysis studies …

Telomerase reverse transcriptase (TERT) promoter mutation correlated with intratumoral heterogeneity in hepatocellular carcinoma

WT Kwa, K Effendi, K Yamazaki, N Kubota… - Pathology …, 2020 - Wiley Online Library
Telomerase reverse transcriptase (TERT) promoter mutations are frequently observed in
hepatocellular carcinoma (HCC); however, the impact of TERT promoter mutations (TPMs) …

[HTML][HTML] The TERT promoter mutation incidence is modified by germline TERT rs2736098 and rs2736100 polymorphisms in hepatocellular carcinoma

X Yuan, G Cheng, J Yu, S Zheng, C Sun, Q Sun, K Li… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Telomerase activation via induction of the catalytic component telomerase reverse
transcriptase (TERT) plays essential roles in malignant transformation. TERT promoter …

[PDF][PDF] Telomerase reverse transcriptase promoter mutations in hepatocellular carcinogenesis

ZX Ma, CM Yang, MG Li, H Tu - cancer, 2019 - academia.edu
Through several studies exploiting next-generation sequencing, we are obtaining a clearer
picture of the complex genetic and molecular landscape of hepatocellular carcinoma (HCC) …

[HTML][HTML] Clinical significance of telomerase reverse-transcriptase promoter mutations in hepatocellular carcinoma

F Pezzuto, F Izzo, P De Luca, E Biffali, L Buonaguro… - Cancers, 2021 - mdpi.com
Simple Summary Activating mutations in the promoter region of TERT (TERTp) gene are
frequently observed in low-and high-grade dysplastic nodules and defined as early events …

[HTML][HTML] Clinicopathological characteristics of TERT promoter mutation and telomere length in hepatocellular carcinoma

HW Lee, TI Park, SY Jang, SY Park, WJ Park, SJ Jung… - Medicine, 2017 - journals.lww.com
Promoter mutations in telomerase reverse transcriptase (TERT) and telomere length have
been studied in various tumors. In the present study, the frequency and clinical …

Human telomerase reverse transcriptase gene promoter mutation in serum of patients with hepatocellular carcinoma

S Ako, K Nouso, H Kinugasa, H Matsushita… - Oncology, 2020 - karger.com
Background: Mutations in the human telomerase reverse transcriptase (hTERT) gene
promoter have been reported in hepatocellular carcinoma (HCC); however, analyses of …

[HTML][HTML] Genomic and transcriptomic somatic alterations of hepatocellular carcinoma in non-cirrhotic livers

ZL Skidmore, J Kunisaki, Y Lin, KC Cotto, EK Barnell… - Cancer genetics, 2022 - Elsevier
Worldwide, there are approximately 750,000 new cases of hepatocellular carcinoma (HCC)
each year [1]. Although HCC has the 5th highest incidence rate in men and 9th highest …

[HTML][HTML] Telomere length is key to hepatocellular carcinoma diversity and telomerase addiction is an actionable therapeutic target

M Ningarhari, S Caruso, TZ Hirsch, Q Bayard… - Journal of …, 2021 - Elsevier
Background & Aims Telomerase activation is the earliest event in hepatocellular carcinoma
(HCC) development. Thus, we aimed to elucidate the role of telomere length maintenance …